Publications

Home >> Research >> Publications


Impact Factor


November 2026
Journal of Synchrotron Radiation
Sinha M, Yu B, Mendes Da Silva R, Rölleke U, Luley P, Tiburcy M, Zimmermann WH, Burghammer M, Köster S
October 2026
Signal Transduction and Targeted Therapy
Brand C, Zinke C, Syed Ali G, Hübscher D, Ajmail K, Seedorf A, Steinker P, Treu F, Jung P, Eberl H, Li Y, Dybkova N, Feld L, Ghadri JR, Templin C, Sossalla S, Maack C, Voigt N, Nikolaev VO, Wollnik B, Streckfuss-Bömeke K
October 2026
Molecular Therapy
Roos L, Diniz AM, Koert E, Schilling M, Uhl M, Thirumalai A, Aakhte M, Kusch K, Huisken J, Moser T, Pape C
October 2026
EMBO Molecular Medicine
Albrecht N, Koert E, Vavakou A, Roos L, Jablonski L, Marcoleta JP, Cardona Audi J, Alfken J, Klein E, Ruther P, Mager T, Kusch K, Moser T
October 2026
Science Signaling
Mücher B, Garrido-Charles A, Wietek J, Köhler I, Grömmke M, Frischmuth T, Cyganek L, Rost BR, Bruegmann T, Schmitz D, Dalkara D, Wahle P, Siveke I, Herlitze S
September 2026
Cardiovascular Research
Akerman E, Capel RA, Rog-Zielinska EA, Winbo A, Aston D, Falter F, Bin Abdul Mu-U-Min R, Read MJ, Bose SJ, Swietach P, Wang J, Corbett AD, Koschinski A, Calamaio S, Melgari D, Prevostini R, Rivolta I, Ayagama T, Jenkin I, Simon JN, Fakuade FE, Pronto JR, Sharma P, Melia C, Song Q, Booth MJ, Platt FM, Lei M, Hester S, Fischer R, Voigt N, Schotten U, Verheule S, Dev A, Held M, Waring T, Galione A, Keller M, Bracher F, Zaccolo M, Terrar DA, Burton RAB
September 2026
Communications Engineering
Wendland R, Schmieder F, Sikandar MA, Knüppel FP, Zimmermann WH, Bergmann O, Büttner L, Czarske J
September 2026
BioRxiv
Palacios-Contreras E, an der Brugge K, Fell J, Stephan T, Amedei H, Lenz C, Pesek J, Taudte VR, Lange F, Jakobs S, Sossalla S, Zelarayan LC, Cabrera-Orefice A, Cyganek L, Pavez-Giani MG
September 2026
Human Gene Therapy
Bögershausen N, Yigit G, Fedorenko A, Bayati R, Döring P, Gerhardt M, Strohmeyer C, Gutiérrez-Gutiérrez O, Javanmardi B, Gaubert M, Kaygusuz E, Krawitz P, Ueffing M, Hoerauf H, Feltgen N, Michalakis S, Büning H, Cyganek L, Wollnik B
September 2026
Circulation Research
Linke WA, Kümper L, Fomin A, Martin I, Ignatyeva N, Hashimoto K, Mohr C, Bässler J, Gärtner A, Ohira M, Hanashima A, Klotz A, Schiffer K, Voelkel T, Freundt JK, Hucke A, Koser F, Zhang T, Hobbach AJ, Glass IA; Birth Defects Research Laboratory; Gummert JF, Dos Remedios CG, van Heesch S, Ruiz-Orera J, Mohri S, Hubner N, Regnier M, Milting H, Mayans O, Unger A, Ebert A

Authors

Linke WA, Kümper L, Fomin A, Martin I, Ignatyeva N, Hashimoto K, Mohr C, Bässler J, Gärtner A, Ohira M, Hanashima A, Klotz A, Schiffer K, Voelkel T, Freundt JK, Hucke A, Koser F, Zhang T, Hobbach AJ, Glass IA; Birth Defects Research Laboratory; Gummert JF, Dos Remedios CG, van Heesch S, Ruiz-Orera J, Mohri S, Hubner N, Regnier M, Milting H, Mayans O, Unger A, Ebert A

Journal

Circulation Research

Citation

Circ Res. 2026 Sep 10.

Abstract

Background: Nx3 (novex-3) is an exceptionally small isoform of the giant protein titin, whose structural and functional roles within the sarcomere remain poorly understood.
Methods and results: We used a comprehensive, multimodal approach to define the key properties of Nx3 in healthy and failing hearts, including its abundance relative to FLT (full-length titin), sarcomeric localization, protein interactions, and functional relevance in mouse and human cardiomyocytes under physiological and pathological conditions. Using Western blotting, quantitative polymerase chain reaction, total RNA sequencing, and ribosome profiling, we show that Nx3 is constitutively expressed from fetal development through adulthood. In adult mouse and human myocardium, Nx3 accounts for ≈20% to 25% of total titin protein, despite representing only ≈8% to 14% at the transcript level. Immunoelectron microscopy and binding studies reveal that Nx3 adopts a nonlinear configuration within the sarcomere: its N terminus is anchored at the Z-disk, although the proximal portion of its unique region encoded by Ttn exon 48, enriched in coiled-coil motifs, engages laterally with adjacent titin or Nx3 molecules at the Z-disk/I-band interface. Its monomeric C terminus extends toward the A-band but remains confined to the Z-/I-band region. This architecture confers enhanced stability and flexibility to the Z-disk under mechanical load. Protein interaction studies, including yeast 2-hybrid screening and coimmunoprecipitation, identified Pin1 (peptidyl-prolyl cis-trans isomerase NIMA-interacting 1) and TBC1D4 (TBC1 domain family member 4) as binding partners of the Nx3 C terminal region, suggesting participation in signaling networks regulating cardiomyocyte metabolism. Genetic ablation of Nx3 in mouse hearts and human induced pluripotent stem cell-derived cardiomyocytes indicates that, although dispensable for sarcomere assembly, Nx3 is required for optimal Z-disk organization and mechanical performance. In end-stage dilated cardiomyopathy, human hearts exhibit dysregulated Nx3 expression, with reduced protein abundance relative to nonfailing controls and focal Z-disk disruption, likely contributing to impaired contractile function.
Conclusions: Nx3 regulates Z-disk stability and modulates signaling pathways that optimize cardiac performance, and its dysregulation contributes to heart failure pathogenesis.

DOI

10.1161/CIRCRESAHA.125.327786
 
Pubmed Link

X
EN DE
X
X